Heyu Biological Technology Corporation
HYBT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $148 | $128 | $1 | $0 |
| - Cash | $0 | $1 | $0 | $0 |
| + Debt | $7 | $0 | $0 | $0 |
| Enterprise Value | $155 | $128 | $1 | $0 |
| Revenue | $3 | $3 | $0 | $0 |
| % Growth | 7.1% | 3,289.4% | -18.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 6.3% | 2.6% | 65.3% | 68.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -13.1% | -17.6% | -336.6% | -168.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -16.5% | -14.2% | -336.1% | -169% |
| EPS Diluted | -0.001 | -0.001 | -0 | -0 |
| % Growth | -12.5% | -166.7% | -50% | – |
| Operating Cash Flow | -$7 | $1 | -$0 | -$0 |
| Capital Expenditures | -$4 | -$41 | $0 | $0 |
| Free Cash Flow | -$11 | -$40 | -$0 | -$0 |